The U.S. House on Wednesday passed and sent to President Biden a $1.9 trillion COVID-19 relief and economic recovery bill with provisions affecting the 340B program and its participants. Biden will sign the bill at the White House tomorrow.
The amended bill includes language that potentially could lead to 340B ceiling prices on some branded drugs being set lower than $0.01 starting in 2024. The bill also would allow outpatient drugs used for COVID-19 prevention or treatment to be included in the Medicaid drug rebate program.
The U.S. House on Wednesday passed and sent to President Biden a $1.9 trillion COVID-19 relief and economic recovery bill with provisions affecting the 340B program and its participants. Biden will sign the bill at the White House tomorrow.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
